Regeneron’s Billionaire Founder Battles The Drug Pricing System
Regeneron’s Leonard Schleifer condemns greed at other drug firms. But what about the $37,000 price tag on his eczema drug?
Regeneron’s Leonard Schleifer condemns greed at other drug firms. But what about the $37,000 price tag on his eczema drug?
Microplastics, PFAS and mold: Common kitchen items may be impacting your health and safety. Here’s how to reduce your risk.
A recent study identifies 14 genes linked to enhanced weight loss when combined with moderate exercise, such as running for 30 minutes three times a…
Spain-based Inbrain Neuroelectronics plans first-in-human study to show safety of its graphene-based technology in direct contact with human brain while also developing a second interface…
Using a cutting-edge technique, Hopkins researchers present a potential clinical tool to predict waist circumference and identify patients at risk for obesity complications
The company was valued at $1 billion in 2021.
Johns Hopkins launches OneNeuro, a cross-disciplinary initiative to utilize emerging technologies and AI to finally crack the code on the enigmatic human brain
Johns Hopkins launches OneNeuro, a cross-disciplinary initiative to utilize emerging technologies and AI to finally crack the code on the enigmatic human brain
Source Credits: @sony-technology4466
Thanks to digital health technologies, the healthcare industry is undergoing a transformative shift. This evolution is not just about adopting new technologies but about fundamentally…
In the past 50 years, Vietnam has undergone an incredible transformation from the brink of catastrophe to a hub of innovation. Warner Bros. Discovery, in…